159 related articles for article (PubMed ID: 19788873)
1. How can systems pathology help us personalize cancer therapy?
Faratian D; Langdon SP; Harrison DJ
Discov Med; 2009 Aug; 8(41):81-6. PubMed ID: 19788873
[TBL] [Abstract][Full Text] [Related]
2. Digital pathology in personalized cancer therapy.
Słodkowska J; García-Rojo M
Stud Health Technol Inform; 2012; 179():143-54. PubMed ID: 22925795
[TBL] [Abstract][Full Text] [Related]
3. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
Roukos DH
Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
[TBL] [Abstract][Full Text] [Related]
4. Role of oncoproteomics in the personalized management of cancer.
Jain KK
Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798
[TBL] [Abstract][Full Text] [Related]
5. Progress towards personalized medicine.
Bates S
Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
[TBL] [Abstract][Full Text] [Related]
6. Cancer-related forecast biomarkers: a topic in focus of the Worldwide Innovative Network in Personalized Cancer Medicine (WIN).
Schmitt M; Lazar V
Bioanalysis; 2010 May; 2(5):851-3. PubMed ID: 21083216
[No Abstract] [Full Text] [Related]
7. Role of biological therapies in the development of personalized medicine.
Jain KK
Expert Opin Biol Ther; 2012 Jan; 12(1):1-5. PubMed ID: 22107592
[TBL] [Abstract][Full Text] [Related]
8. Circadian timing in cancer treatments.
Lévi F; Okyar A; Dulong S; Innominato PF; Clairambault J
Annu Rev Pharmacol Toxicol; 2010; 50():377-421. PubMed ID: 20055686
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapies for non-small cell lung cancer.
Dempke WC; Suto T; Reck M
Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
[TBL] [Abstract][Full Text] [Related]
10. Reducing diagnostic error with computer-based clinical decision support.
Greenes RA
Adv Health Sci Educ Theory Pract; 2009 Sep; 14 Suppl 1():83-7. PubMed ID: 19669915
[TBL] [Abstract][Full Text] [Related]
11. The surgical pathology report as an educational tool for cancer patients.
Strobel SL; Tatchell T
Ann Clin Lab Sci; 2002; 32(4):363-8. PubMed ID: 12458887
[TBL] [Abstract][Full Text] [Related]
12. Modelling in surgical oncology--part III: massive data sets and complex systems.
Rew DA
Eur J Surg Oncol; 2000 Dec; 26(8):805-9. PubMed ID: 11200075
[TBL] [Abstract][Full Text] [Related]
13. Twenty-first century pathology sign-out.
Tomlins S; Robinson D; Penny RJ; Hess JL
Clin Lab Med; 2012 Dec; 32(4):639-50. PubMed ID: 23078664
[TBL] [Abstract][Full Text] [Related]
14. Mathematical modeling of cancer progression and response to chemotherapy.
Sanga S; Sinek JP; Frieboes HB; Ferrari M; Fruehauf JP; Cristini V
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1361-76. PubMed ID: 17069522
[TBL] [Abstract][Full Text] [Related]
15. DNase1: a new personalized therapy for cancer?
Rosner K
Expert Rev Anticancer Ther; 2011 Jul; 11(7):981-4. PubMed ID: 21806320
[No Abstract] [Full Text] [Related]
16. Improving drug safety using computational biology.
Cook D
IDrugs; 2010 Feb; 13(2):85-9. PubMed ID: 20127559
[TBL] [Abstract][Full Text] [Related]
17. Human tissue in systems medicine.
Caie PD; Schuur K; Oniscu A; Mullen P; Reynolds PA; Harrison DJ
FEBS J; 2013 Dec; 280(23):5949-56. PubMed ID: 24118991
[TBL] [Abstract][Full Text] [Related]
18. [Advances in molecular oncologic pathology].
Chen L
Ai Zheng; 2007 Jan; 26(1):106-12. PubMed ID: 17222378
[TBL] [Abstract][Full Text] [Related]
19. Personalized medicine: individualized care of cancer patients.
Ely S
Transl Res; 2009 Dec; 154(6):303-8. PubMed ID: 19931196
[TBL] [Abstract][Full Text] [Related]
20. [Addiction and brief-systemic therapy: working with compulsion].
Cottencin O; Doutrelugne Y; Goudemand M; Consoli SM
Encephale; 2009 Jun; 35(3):214-9. PubMed ID: 19540406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
